Skip to main content

Prevalence of Prostate Cancer in High Boron-Exposed Population: A Community-Based Study

Abstract

We investigated the possible relationship between boron exposure and prostate cancer (PCa) for men living and being employed at boron mines in villages with rich boron minerals. Out of 456 men studied, 159 were from villages with rich boron sources and boron levels in drinking water of >1 mg L−1 and these men formed the study group, while 63 from villages with rich boron sources and boron levels in drinking water of <1 mg L−1 were enrolled into control group 1. A further 234 subjects from other villages with no boron mines were considered as control group 2. Prostate specific antigen (PSA) levels could be obtained from a total of 423 men. Urinary boron concentration as an indicator of boron exposure in 63 subjects, prostatic volumes by transrectal ultrasonography in 39 subjects, and prostatic biopsies in 36 subjects were obtained for study and control groups. The daily boron exposure was calculated according to urinary boron levels. Although there was no significant difference among the groups in terms of total PSA levels, the number of subjects with tPSA ≥2.5 and tPSA ≥10.0 ng dL−1 prostatic volumes in men whose prostates were biopsied (p < 0.012) was significantly lower in the study group as compared with those in the control group 2. These results suggested that high exposure to boron might have an implication within the prostatic cellular processes related to hyperplasia and carcinogenesis, even though we did not find a statistically significant association between PCa and boron exposure.

This is a preview of subscription content, access via your institution.

References

  1. Bosland MC (2000) The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27:39–66

    PubMed  Article  CAS  Google Scholar 

  2. Hunt CD, Herbel JL, Nielsen FH (1997) Metabolic responses of postmenopausal women to supplemental dietary boron and aluminum during usual and low magnesium intake: boron, calcium, and magnesium absorption and retention and blood mineral concentrations. Am J Clin Nutr 65:3803–3813

    Google Scholar 

  3. Gallardo-Williams MT, Chapin RE, King PE, Moser GJ, Goldsworthy TL et al (2004) Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice. Toxicol Pathol 32:73–78

    PubMed  Article  CAS  Google Scholar 

  4. Cui Y, Winton MI, Zhang ZF, Rainey C, Marshall J et al (2004) Dietary boron intake and prostate cancer risk. Oncol Rep 11:887–892

    PubMed  CAS  Google Scholar 

  5. Jamal A, Siegel R, Ward E et al (2008) Cancer statistics. CA Cancer J Clin 58:71–96

    Article  Google Scholar 

  6. Winters SJ, Brufsky A, Weissfeld J, Trump DL, Dyky MA et al (2001) Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 50:1242–1247

    PubMed  Article  CAS  Google Scholar 

  7. Yazbeck C, Kloppmann W, Cottier R, Sahuquillo J, Debotte G et al (2005) Health impact evaluation of boron in drinking water: a geographical risk assessment in Northern France. Environ Geochem Health 27:419–427

    PubMed  Article  CAS  Google Scholar 

  8. Barranco WT, Hudak PF, Eckhert CD (2007) Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States). Cancer Cause Control 18:71–77

    Article  Google Scholar 

  9. Barranco WT, Kim DH, Stella SL Jr, Eckhert CD (2009) Boric acid inhibits stored Ca2+ release in DU-145 prostate cancer cells. Cell Biol Toxicol 25:309–320

    PubMed  Article  CAS  Google Scholar 

  10. Sayli BS, Tüccar E, Elhan AH (1998) An assessment of fertility in boron-exposed Turkish subpopulations. Reprod Toxicol 2:297–304

    Article  Google Scholar 

  11. Simsek A, Velioglu SY, Coskun LA, Saylı BS (2003) Boron concentrations in selected foods from borate-producing regions in Turkey. J Sci Food Agric 83:586–592

    Article  CAS  Google Scholar 

  12. Lekili M, Müezzinoglu T, Ceylan Y, Temeltas G, Büyüksu C (2006) Which one is responsible for pain during transrectal guided prostate biopsy: prostate or anal canal. Panminerva Med 48:200–201

    PubMed  CAS  Google Scholar 

  13. Pahl VM, Culver BD, Strong PL, Murray FJ, Vaziri ND (2001) The effect of pregnancy on renal clearance of boron in humans: a study based on normal dietary intake of boron. Toxicol Sci 60:252–256

    PubMed  Article  CAS  Google Scholar 

  14. Sutherland B, Leslie R, Woodhouse PS, Janet CK (1999) Boron balance in humans. J Trace Elem Exp Med 12:271–284

    Article  CAS  Google Scholar 

  15. Korkmaz M, Sayli U, Sayli BS, Bakirdere S, Titretir S, Ataman OY, Keskin S (2007) Estimation of human daily boron exposure in a boron-rich area. Br J Nutr 98:571–575

    PubMed  Article  CAS  Google Scholar 

  16. Korkmaz M, Yenigün M, Bakırdere S, Ataman OY, Keskin S, Müezzinoğlu T, Lekili M (2010) Effects of chronic boron exposure on semen profile. Biol Trace Elem Res. doi:10.1007/s12011-010-8928-2

    PubMed  Google Scholar 

  17. Eser S, Zorlu F, Divrik RT, Cal C, Ozkan M et al (2009) Incidence and epidemiological features of cancers of the genitourinary tract in Izmir between 1993–2002. Asian Pac J Cancer Prev 10:491–496

    PubMed  Google Scholar 

  18. Matlaga BR, Eskew LA, McCullough DL (2003) Prostate biopsy: indications and technique. J Urol 169:12–19

    PubMed  Article  Google Scholar 

  19. Barranco WT, Eckhert CD (2004) Boric acid inhibits human prostate cancer cell proliferation. Cancer Lett 216:21–29

    PubMed  Article  CAS  Google Scholar 

  20. Barranco WT, Eckhert CD (2006) Cellular changes in boric acid-treated DU-145 prostate cancer cells. Br J Cancer 94:884–890

    PubMed  Article  CAS  Google Scholar 

  21. Bosland MC (2009) The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27:39–66

    Google Scholar 

  22. Naghii MR, Samman S (1997) The effect of boron supplementation on its urinary excretion and selected cardiovascular risk factors in healthy male subjects. Biol Trace Elem Res 56:273–286

    PubMed  Article  CAS  Google Scholar 

  23. Hausdorff WP, Sekura RD, Aguilera G, Catt KJ (1987) Control of aldosterone production by angiotensin II is mediated by two guanine nucleotide regulatory proteins. Endocrinology 120:1668–1678

    PubMed  Article  CAS  Google Scholar 

  24. Fong YK, Milani S, Djavan B (2005) Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia. Curr Opin Urol 15:35–38

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

This research was supported by the National Boron Research Institute, grant no. AR-GE/6.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mehmet Korkmaz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Müezzinoğlu, T., Korkmaz, M., Neşe, N. et al. Prevalence of Prostate Cancer in High Boron-Exposed Population: A Community-Based Study. Biol Trace Elem Res 144, 49–57 (2011). https://doi.org/10.1007/s12011-011-9023-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-011-9023-z

Keywords

  • Prostatic neoplasm
  • Epidemiology
  • Boron intake